Sodium nitrite as a therapeutic agent for central nervous system diseases.
Pluta
Ryszard M
RM
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892-1662, USA.
Oldfield
Edward H
EH
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000502:physiology; D001927:Brain Diseases / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D002536:Cerebral Arteries / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D006454:Hemoglobins / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism; D020030:Nitric Oxide Donors / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D012977:Sodium Nitrite / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D014665:Vasodilator Agents / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D020301:Vasospasm, Intracranial / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*
D006454:Hemoglobins; D020030:Nitric Oxide Donors; D014665:Vasodilator Agents; D009569:Nitric Oxide; C100003:deoxyhemoglobin; D012977:Sodium Nitrite